• 21Shares submits INJ ETF application, adding to its multiple product pipeline.
• Filing positions Injective among the few digital assets with multiple ETF offerings.
• Despite the ETF application, the coin’s price declined 4.5% in the last day.

Exchange-traded product issuer 21Shares has filed an application for an Injective ETF and expanded the institutional investment vehicles available for the altcoin. The submission places INJ among a select group of digital assets attracting multiple ETF product developments.

21Shares ranks among the world’s largest exchange-traded product issuers with extensive experience in cryptocurrency investment vehicles. The company’s filing for INJ follows its track record of launching products for various digital assets.

Injective stated the filing serves as a “major signal of growing institutional interest” in the protocol. The develo…

Read The Full Article 21Shares Files INJ ETF as Injective Joins Elite Group With Multiple ETF Bids On Coin Edition.

• 21Shares submits INJ ETF application, adding to its multiple product pipeline.
• Filing positions Injective among the few digital assets with multiple ETF offerings.
• Despite the ETF application, the coin’s price declined 4.5% in the last day.

Exchange-traded product issuer 21Shares has filed an application for an Injective ETF and expanded the institutional investment vehicles available for the altcoin. The submission places INJ among a select group of digital assets attracting multiple ETF product developments.

21Shares ranks among the world’s largest exchange-traded product issuers with extensive experience in cryptocurrency investment vehicles. The company’s filing for INJ follows its track record of launching products for various digital assets.

Injective stated the filing serves as a “major signal of growing institutional interest” in the protocol. The develo…

Read The Full Article 21Shares Files INJ ETF as Injective Joins Elite Group With Multiple ETF Bids On Coin Edition.